News

ORIC Pharmaceuticals Invites Shareholders to Upcoming Conferences

ORIC Pharmaceuticals Invites Shareholders to Upcoming Conferences

ORIC Pharmaceuticals to Attend Major Investor Conferences

ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC), a leading clinical stage oncology company focused on developing innovative treatments to combat therapeutic resistance, is making waves in the investment community. The company has announced its participation in several important investor conferences scheduled for November, aimed at enhancing shareholder engagement and transparency.

Key Events on the Horizon

During this pivotal month, ORIC Pharmaceuticals is set to engage with investors through two notable events:

Guggenheim's Inaugural Healthcare Innovation Conference

On the first day of the conference, ORIC's management team will participate in a fireside chat scheduled for November 11. This event will provide a unique platform for discussing their strategic vision, highlighting innovative projects, and addressing questions from investors.

Jefferies London Healthcare Conference

Following the Guggenheim event, ORIC will also be featured at the Jefferies London Healthcare Conference on November 21. This is another opportunity to connect with investors and share insights into the progress of their groundbreaking oncology therapies.

Live Broadcasts and Availability

Both discussions from the conferences will be broadcast live, allowing a broader audience to participate and gain insights into ORIC Pharmaceuticals' operations. Interested investors can find links to the live webcasts on the company's official website, where recordings will remain accessible for 90 days post-event.

Understanding ORIC Pharmaceuticals

Founded in California, ORIC Pharmaceuticals is dedicated to changing the landscape of cancer treatment by developing therapies that overcome resistance mechanisms. Their pipeline includes several promising candidates designed to address various types of cancer:

Innovative Product Candidates

1. **ORIC-114**: A first-in-class brain-penetrant inhibitor that specifically targets EGFR exon 20 and HER2 exon 20 mutations, this therapy is being developed for multiple genetically defined cancers.

2. **ORIC-944**: This novel allosteric inhibitor targets the polycomb repressive complex 2 (PRC2) via the EED subunit and is under development for prostate cancer treatment.

3. **ORIC-533**: An orally bioavailable small molecule that inhibits CD73, involved in resistance to chemotherapy and immunotherapy, currently in development for multiple myeloma.

In addition to these leading candidates, ORIC is actively pursuing other precision medicines aimed at tackling various resistance mechanisms associated with cancer treatments.

Company Commitment and Vision

ORIC's commitment to enhancing patient outcomes through innovative treatments underscores its role in the biotechnology sector. The ongoing development of therapies designed to overcome resistance signifies a step forward for cancer patients facing challenging circumstances.

Connect with ORIC Pharmaceuticals

To learn more about ORIC Pharmaceuticals and their initiatives, you can visit their official site and follow them across social media platforms. They are dedicated to keeping investors and stakeholders informed about their journey toward making a significant impact in oncology.

Frequently Asked Questions

What is ORIC Pharmaceuticals known for?

ORIC Pharmaceuticals focuses on developing innovative oncology treatments that aim to overcome mechanisms of therapeutic resistance.

What conferences is ORIC participating in this November?

ORIC will participate in Guggenheim's Inaugural Healthcare Innovation Conference and the Jefferies London Healthcare Conference.

How can investors access the conference discussions?

Investors can access live webcasts of the discussions through the investor section of ORIC's website, with replays available for 90 days after the events.

What are ORIC's lead product candidates?

ORIC's lead product candidates include ORIC-114, ORIC-944, and ORIC-533, targeting various cancer types and mechanisms of resistance.

Where is ORIC Pharmaceuticals located?

ORIC Pharmaceuticals has offices in South San Francisco and San Diego, California.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Palatin Prepares for FY27 Results Amid Market Curiosity

Updated Category News Views 116

Mark Your Calendars, Investors! Folks grumble about the mundane task of checking fiscal calendars, but without this intel, where are we? On November 17, 2026, Palatin Technologies (NASDAQ:PTN) is slated to release their Q1 Fiscal Year 2027 operating results bright and early, before most of us have even sipped our coffee. The buzz around these numbers is as electric as any...

Continue Reading
Walmart Tops 2026 Recall List: 81 Notices, Food Issues Lead

Updated Category News Views 78

Walmart Behind 81 Recalls: Scrutinizing 2026's Top Contender For an outfit that prides itself on shaking up shopping carts coast to coast, Walmart's stumble onto the recall hotseat this year is a head-scratcher. Imagine leading with 81 official recalls—that's more than a flash in the pan, it's the whole frying pan catching fire. Target and Costco aren't slouches, but...

Continue Reading
The Melt Expands with Key Texas Franchise Deal

Updated Category News Views 83

Throwing Down the Gauntlet: The Melt Expands If there's one thing I've learned after decades watching these restaurant chains multiply like rabbits it’s this: when a veteran gets involved, you perk up. The Melt has done just that by roping in Syed Ahmad—a name that actually means something in this game—to open eight new locations in the Lone Star State. It isn't...

Continue Reading
BETR Investors Face Action: Nov. 20 Deadline Nears

Updated Category News Views 121

High Stakes for BETR Shareholders If you're holding shares in Better Home & Finance Holding Company, right now might feel like you're at a craps table with emptying pockets. BETR, trading under NASDAQ, has become the center of a legal hurricane, with investors eyeing the November 20th deadline to join a securities class action led by Hagens Berman. The class period in...

Continue Reading
Fly-E Faces Revenue Drop Amid Retail Restructuring

Updated Category News Views 153

Downturn Despite Strategic Restructuring Today, we're diving into Fly-E Group, Inc. (NASDAQ:FLYE) and the latest shakeup in their financials—spoiler alert, it's riding a downward slope. Quarter two of fiscal 2027 didn't exactly shine a light on profitability. Net revenues slid, dropping to $2.6 million this quarter, down from $3.9 million the previous year. Tack that up...

Continue Reading
Data Center Transformers on the Brink of a Boom

Updated Category News Views 300

A Flash Look: Powering Up Data Centers Look, if you're thinking of sidestepping data center transformers as just another cog in the machine, think again. This market's set to balloon—doubling from $5.59 billion in 2026 to a jaw-dropping $10.72 billion by 2031. We're talking a chunky 13.9% CAGR. Not every bit of news grabs you by the lapels, but this one does. What’s...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 74

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 194

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
LEOTEK's AI Tech Shaping Smarter Cities at COP31

Updated Category News Views 103

AI-Powered Evolution in Urban Infrastructure Hang on to your hats, folks, 'cause LEOTEK is turning heads at COP31 with its AI-driven transformation of urban landscapes. As cities stretch at the seams to keep up with modern challenges, LEOTEK's got more than a few tricks up its sleeve with its trademark blend of traffic system intelligence and energy management prowess....

Continue Reading
YYForce Expands in UAE with Key Hospitality Wins

Updated Category News Views 170

Unveiling YYForce's Middle East Strategy Smack in the middle of an aggressive Middle Eastern expansion, YYForce (NASDAQ: YFOR) is making waves with some new headline-grabbing contracts in the UAE. This ain't just a side hustle—it's big time. They're planting their flag across the luxury hospitality sector like they're going for a moon landing. The recent announcement...

Continue Reading

Top 5 Most Recently Viewed Articles

Henning Cheese Excels with Top Awards at National Contest

Updated Category News Views 128

Henning Cheese Shines at the National Cheese Contest Henning Cheese has achieved remarkable recognition at the recent U.S. Championship Cheese Contest, where it secured multiple first-place awards and an impressive overall ranking. The company's standout entry, Onion & Chive Cheddar, once again placed within the top 20 overall, marking a significant achievement for the...

Continue Reading
Actelis Networks Introduces Innovative Cryptocurrency Strategy

Updated Category News Views 116

Actelis Networks Embraces Cryptocurrency for Treasury Management Actelis Networks, Inc. (NASDAQ: ASNS), based in Fremont, California, has taken an exciting step forward in its corporate strategy. The company, renowned for its market-leading cyber-hardened networking solutions for IoT and broadband applications, has announced an innovative treasury management strategy that...

Continue Reading
Nykredit Invest Balance Announces Trading Suspension with Key Details

Updated Category News Views 201

Nykredit Invest Balance Trading Suspension Nykredit Portefølje Administration A/S has made a significant decision by requesting Nasdaq Copenhagen to suspend trading in selected funds managed by their team. This step is essential as technical issues are currently preventing the correct calculation of the Net Asset Values (NAV) for these funds. Details of the Fund...

Continue Reading
European Wax Center Announces New Equity Grants for Employees

Updated Category News Views 179

Overview of European Wax Center's Inducement Grants European Wax Center, Inc. (NASDAQ: EWCZ), renowned for its exceptional out-of-home waxing services, has recently made a significant announcement regarding employee equity grants. This initiative aims to strengthen its position as a leading franchisor and operator in the industry. Effective from a noted date, the...

Continue Reading
Bread Financial Holdings: Navigating Challenges and Growth Ahead

Updated Category News Views 472

Understanding Bread Financial Holdings and Its Journey Bread Financial Holdings, Inc. (NYSE: BFH) is a significant entity in the U.S. consumer finance realm, facing a dynamic environment of regulatory obstacles and competitive landscapes. With an ongoing strategic shift, the company is attracting the attention of both analysts and investors as it seeks to carve a new path...

Continue Reading